在税收支持医疗体系中教育与收入对急性髓系白血病患者治疗和结局的影响:一项全国性基于人群的队列研究
该研究利用丹麦2000至2014年全国AML患者个体水平社会经济与临床数据,比较不同教育/收入组的治疗强度、移植率和生存。结果显示教育程度而非收入影响年轻患者的移植率和生存,且近期生存改善仅见于高教育组。
要点
- 在全民医疗体系中,教育程度而非收入影响AML年轻患者的移植率和生存。
- 高教育患者接受异基因移植的比例高于低教育患者(16.3% vs 8.7%)。
- 5年生存改善仅见于高教育组(从39%升至58%),组间生存差距扩大。
核心结论
- 在全民医疗体系中,教育水平而非收入影响年轻AML患者的移植率和生存。
- 近期生存改善仅惠及高教育患者。
研究设计与样本
- 基于人群的队列研究,纳入2000至2014年所有丹麦AML患者,共2992例。
- 使用个体水平社会经济与临床数据,采用 logistic 回归(比值比)和 Cox 回归(风险比)分析。
主要发现
- 2992例患者中1588例(53.1%)接受强化化疗。
- 高教育患者较低教育患者更常接受异基因移植(16.3% vs 8.7%)。
- 在小于60岁的强化治疗患者中,低教育组1年生存66.7%(调整HR 1.47,95%CI 1.11-1.93),中等教育组67.6%(调整HR 1.55,95%CI 1.21-1.98),均低于高教育组76.9%。
- 研究期间5年生存改善仅见于高教育组(从39%升至58%),组间生存差距扩大。
- 在老年患者中,低教育组较高教育组接受强化治疗更少(30% vs 48%;调整OR 0.65,95%CI 0.44-0.98);但在强化治疗者中缓解率和生存未受影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose Previous US studies have shown that socioeconomic status (SES) affects survival in acute myeloid leukemia (AML). However, no large study has investigated the association between education or income and clinical characteristics, treatment, and outcome in AML. Methods To investigate the effects of education and income in a tax-supported health care system, we conducted a population-based study using individual-level SES and clinical data on all Danish patients with AML (2000 to 2014). We compared treatment intensity, allogeneic transplantation, and response rates by education and income level using logistic regression (odds ratios). We used Cox regression (hazard ratios [HRs]) to compare survival, adjusting for age, sex, SES, and clinical prognostic markers. Results Of 2,992 patients, 1,588 (53.1%) received intensive chemotherapy. Compared with low-education patients, highly educated patients more often received allogeneic transplantation (16.3% v 8.7%). In intensively treated patients younger than 60 years of age, increased mortality was observed in those with lower and medium education (1-year survival, 66.7%; adjusted HR, 1.47; 95% CI, 1.11 to 1.93; and 1-year survival, 67.6%; adjusted HR, 1.55; CI, 1.21 to 1.98, respectively) compared with higher education (1-year survival, 76.9%). Over the study period, 5-year survival improvements were limited to high-education patients (from 39% to 58%), increasing the survival gap between groups. In older patients, low-education patients received less intensive therapy (30% v 48%; adjusted odds ratio, 0.65; CI, 0.44 to 0.98) compared with high-education patients; however, remission rates and survival were not affected in those intensively treated. Income was not associated with therapy intensity, likelihood of complete remission, or survival (high income: adjusted HR, 1.0; medium income: adjusted HR, 0.96; 95% CI, 0.82 to 1.12; low income: adjusted HR, 1.06; CI, .88 to 1.27). Conclusion In a universal health care system, education level, but not income, affects transplantation rates and survival in younger patients with AML. Importantly, recent survival improvement has exclusively benefitted highly educated patients.
引用
- Østgård LSG, Nørgaard M, Medeiros BC, et al. Effects of Education and Income on Treatment and Outcome in Patients With Acute Myeloid Leukemia in a Tax-Supported Health Care System: A National Population-Based Cohort Study. J Clin Oncol. 2017. PMID: 28892433. doi:10.1200/JCO.2017.73.6728
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。